Overview

An Interventional Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Spinal Disorders

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
Study Objectives: 1. Primary objective - To assess the pain reduction after 8 weeks treatment from baseline (week 0) 2. Secondary objectives - To assess the pain reduction after 4 weeks treatment from baseline (week 0) - To assess the EQ-5D - To assess physician's overall satisfaction - To assess subject's overall satisfaction - To assess safety
Phase:
Phase 4
Details
Lead Sponsor:
Mundipharma Korea Ltd
Treatments:
Naloxone
Oxycodone